sickle cell disease
sickle cell disease
Revolutionizing Cell and Gene Therapy: A Vital Call to Unify
BIOT
📰 FDA approval of gene therapy & increase in activity highlight need for standardized cell & gene therapy hub. Collaboration is crucial. 💡🤝
World’s First CRISPR Cell Therapy Approved for Sickle Cell – Solvias to Perform Testing
BIOT
📰 Solvias will perform release testing on CASGEVY, the world's first CRISPRCas9 genome-edited cell therapy. 🧪💊🔬✅🌍
Vertex Launches Casgevy: Revolutionary Gene Editing for Genetic Diseases
BIOT
📚 Vertex Pharmaceuticals launches Casgevy, targeting gene editing therapies for sickle cell disease and beta thalassemia. 💰 This move strengthens Vertex's position in genetic diseases and aims for significant impact in the field.
